Factors associated with survival at one year of life in neonates with severe congenital cardiopathy in A National Hospital in Peru

• Published in: Revista peruana de medicina experimental y salud pública Vol. 36; no. 3; pp. 433 - 441
• Main Authors: Torres-Romucho, Camilo E, Uriondo-Ore, Victor G, Ramirez-Palomino, Alberto J, Arroyo-Hernández, Hugo, Loo-Valverde, Maria, Protzel-Pinedo, Ana, Dueñas-Roque, Milagros
• Format: Journal Article
• Language: Spanish
• Published: Peru 01.07.2019
• Subjects: Cohort Studies; Female; Heart Defects, Congenital - mortality; Heart Defects, Congenital - therapy; Heart Diseases - congenital; Heart Diseases - mortality; Heart Diseases - therapy; Hospitals; Humans; Infant; Infant, Newborn; Male; Peru; Retrospective Studies; Risk Factors; Severity of Illness Index; Survival Analysis; Peru
• ISSN: 1726-4642
• DOI: 10.17843/rpmesp.2019.363.4166

To determine factors associated with survival in the first year of life in neonates with severe congenital heart disease treated in a national hospital in Peru. 160 children born between 2012 and 2015 with a diagnosis of severe congenital cardiopathy were studied and admitted to the Neonatology Service of the Edgardo Rebagliati Martins National Hospital of the Peruvian Social Security. The Kaplan-Meier method and the Log-Rank test were used in the survival analysis. Crude and adjusted analyses were performed using Cox regression models. Fifty-two, point 5 percent (52.5%) of patients were male and the most frequent severe congenital cardiopathy was pulmonary atresia (26.3%). Thirty-three, point seven percent (33.7%) of patients died, with a 66.3% (IC95% 58.4-73.0) one-year survival. Prenatal diagnosis improved survival (HRa 0.54, 95% CI 0.30-0.98) while cyanotic cardiopathies (HRa 2.93, 95% CI 1.36-6.34) and the presence of another congenital anomaly (HRa 3.28, 95% CI 1.79-6.01) decreased it; these factors were also significant in a second model stratified by surgical treatment with the exception of the stratified model by complications where a prenatal diagnosis ceased to be significant. Prenatal diagnosis increases survival from severe congenital heart disease. However, cyanotic heart diseases and other congenital anomalies, which decrease this chance, should be considered, if surgery is performed or complications occur.